454248-53-4

Basic information

• Product Name: Tert-Butyl (R)-4-Methyl-2,2-Dioxo-[1,2,3]Oxathiazolidine-3-Carboxylate
• Synonyms: Tert-Butyl (R)-4-Methyl-2,2-Dioxo-[1,2,3]Oxathiazolidine-3-Carboxylate;(R)-tert-Butyl 4-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide;2-Methyl-2-Propanyl (4R)-4-Methyl-1,2,3-Oxathiazolidine-3-Carboxylate 2,2-Dioxide;(4R)-2,2-Dioxido-4-methyl-1,2,3-oxathiazolidine,N-BOCprotected;(R)-4-Methyl-2,2-dioxo-2l6-[1,2,3]oxathiazolidine-3-carboxylic acid tert-butyl ester
• CAS NO: 454248-53-4
• Molecular Formula: C₈H₁₅NO₅S
• Molecular Weight: 237.28
• Mol File: 454248-53-4.mol
• Article Data: 19

Chemical Properties

• Melting Point: 120-121 °C
• Boiling Point: 293.5±23.0 °C(Predicted)
• Appearance: /
• Density: 1.285±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -13.53±0.40(Predicted)
• CAS DataBase Reference: Tert-Butyl (R)-4-Methyl-2,2-Dioxo-[1,2,3]Oxathiazolidine-3-Carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Tert-Butyl (R)-4-Methyl-2,2-Dioxo-[1,2,3]Oxathiazolidine-3-Carboxylate(454248-53-4)
• EPA Substance Registry System: Tert-Butyl (R)-4-Methyl-2,2-Dioxo-[1,2,3]Oxathiazolidine-3-Carboxylate(454248-53-4)

Safety Data

• Hazardous Substances Data: 454248-53-4(Hazardous Substances Data)

Usage

General Description

Tert-Butyl (R)-4-Methyl-2,2-Dioxo-[1,2,3]Oxathiazolidine-3-Carboxylate is a chemical compound that belongs to the oxathiazolidine-3-carboxylate family. Tert-Butyl (R)-4-Methyl-2,2-Dioxo-[1,2,3]Oxathiazolidine-3-Carboxylate is commonly used as a reagent in organic synthesis and pharmaceutical research. It is a white, crystalline solid with a molecular formula of C9H15NO5S and a molecular weight of 253.28 g/mol. Tert-Butyl (R)-4-Methyl-2,2-Dioxo-[1,2,3]Oxathiazolidine-3-Carboxylate is known for its ability to form stable complexes with various metal ions, making it useful in the production of metal-containing materials and catalysts. Additionally, it has potential applications in the development of new drugs and biologically active compounds due to its unique chemical structure and reactivity.

Upstream product

• 129991-09-9 (R)-N-Boc-2-aminobutane 
• 24424-99-5 di-tert-butyl dicarbonate 
• 79069-13-9 (R)-2-tertbutoxycarbonylamino-1-propanol 

Downstream Products

• 1338090-90-6 [(R)-1-methyl-2-(3-trifluoromethylphenyl)ethyl]carbamic acid tert-butyl ester 
• 454248-61-4 (R)-4-methyl-1,2,3-oxathiazolidine 2,2-dioxide 
• 167421-83-2 tert-butyl N-[(1R)-1-methyl-2-phenylethyl]carbamate 
• 847199-90-0 tert-butyl (R)-(1-(1H-indol-3-yl)propan-2-yl)carbamate 

Relevant articles and documents

PROCESSES FOR MAKING SERD TRICYCLIC COMPOUNDS HAVING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY

Provided herein are processes for the preparation of compounds useful in the treatment of cancer.

Synthesis method for tert-butyl 1,2,3-oxathiazolidine-3-carboxylic ester 2,2-dioxide compound

The invention relates to a synthesis method for a tert-butyl 1,2,3-oxathiazolidine-3-carboxylic ester 2,2-dioxide compound. The tert-butyl 1,2,3-oxathiazolidine-3-carboxylic ester 2,2-dioxide compoundhas a structural formula as shown in a formula I which is described in the specification. The synthesis method comprises the step of allowing a compound as shown in a formula II which is described inthe specification with sulfonyl chloride in the presence of an organic solvent to generate the compound as shown in the formula I. The structural formula of the compound as shown in the formula I andthe structural formula of the compound as shown in the formula II are described in the specification. The synthesis method disclosed by the invention is simple to operate; compared with a conventional published two-step method, the synthesis method provided by the invention only needs one step; and the synthesis method is more convenient, reduces byproducts, is high in yield, does not need to usea catalyst and a highly-toxic substance in the reaction, and is safe and low in cost.

SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE

Provided herein are solid forms, salts such as compound B, and formulations of 3-((lR,3R)-l-(2,6-difluoro-4-((l-(3-fluoropropyl) azetidin-3-yl)amino)phenyl)-3-methyl-l,3,4,9-tetrahydro-2H- pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-l-ol, processes and synthesis thereof, and methods of their use in the treatment of cancer.